May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
The Effect of Conditioned Medium from COX-2 Expressing Macrophage on the In Vitro Proliferation of Uveal Melanoma Cell Lines
A.L. Caissie; J.A. Marshall; E. Antecka; I. Zundane; M.N. Burnier Jr.
Author Affiliations & Notes
  • A.L. Caissie
    Ophthalmology, The Henry C. Witelson Ocular Pathology, McGill University, Montreal, PQ, Canada
  • J.A. Marshall
    Ophthalmology, The Henry C. Witelson Ocular Pathology, McGill University, Montreal, PQ, Canada
  • E. Antecka
    Ophthalmology, The Henry C. Witelson Ocular Pathology, McGill University, Montreal, PQ, Canada
  • I. Zundane
    Ophthalmology, The Henry C. Witelson Ocular Pathology, McGill University, Montreal, PQ, Canada
  • M.N. Burnier Jr.
    Ophthalmology, The Henry C. Witelson Ocular Pathology, McGill University, Montreal, PQ, Canada
  • Footnotes
    Commercial Relationships  A.L. Caissie, None; J.A. Marshall, None; E. Antecka, None; I. Zundane, None; M.N. Burnier Jr., None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1558. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Effect of Conditioned Medium from COX-2 Expressing Macrophage on the In Vitro Proliferation of Uveal Melanoma Cell Lines
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      A.L. Caissie, J.A. Marshall, E. Antecka, I. Zundane, M.N. Burnier Jr.; The Effect of Conditioned Medium from COX-2 Expressing Macrophage on the In Vitro Proliferation of Uveal Melanoma Cell Lines . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1558.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: A high number of tumor-associated macrophages (TAM) has been linked to poor prognosis in uveal melanoma. It has previously been shown that TAM express cyclooxygenase-2 (COX-2), a prostaglandin synthase linked to tumorigenic processes such as cell proliferation, migration and invasion. Macrophages, often found at the invading edge of the tumor, have been shown in vitro to inhibit proliferation while stimulating migration of colon carcinoma cell lines. This study aims to investigate the effect of conditioned medium from activated COX-2-expressing macrophages on the in vitro proliferation rate of uveal melanoma cell lines. Methods: The THP-1 human monocyte cell line was differentiated with phorbol 12-myristate 13-acetate (PMA) and stimulated with IFN-γ and LPS to express COX-2. Proliferation rates of five human melanoma cell lines (92.1, SP6.5, MKT-BR, OCM-1 and UW-1) were assayed in triplicate using the tritiated thymidine uptake (TTU) method. TTU results were obtained for cell lines seeded in RPMI medium as well as RPMI medium with interferon-gamma (IFN-γ) and lipopolysaccharide (LPS). These TTU results were compared to results from cell lines seeded in 24 hour conditioned medium from COX-2 expressing macrophages. Results: TTU showed that the rate of tumor cell proliferation was decreased by conditioned medium from activated macrophage. In each cell line, this decrease in proliferation was at least two times greater than that observed in tumor cells with non-conditioned IFN-γ and LPS medium. Conclusions: Conditioned medium from activated COX-2 expressing macrophages decreased the proliferation rate of all uveal melanoma cell lines. COX-2 expressing macrophages in uveal melanoma may inhibit tumor cell proliferation while enhancing other neoplastic properties such as migration and invasion. The mechanisms behind this decrease in proliferation should be investigated further.

Keywords: melanoma • proliferation • oncology 
© 2003, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept